Talk to Sam

(866) 682 9815

Search inside this page

All regions

Free Market Research Guides to Download

Pathology Market Statistics, June 2013

» Read Business News

1-30 of about 32 000 news
Cancer Sector: Meat raises risk of bowel cancer death

Cancer Sector: Meat Raises Risk Of Bowel Cancer Death

  • Industry news
  • 4 hours ago
  • by News Ltd.

ALMOST 2 Queenslanders a week die of bowel cancer caused by eating processed meat, leading the state's chief health officer to call on the public to drastically change their lifestyles. Dr Jeannette Young's warning comes from the recent World Can...

  • Industries : Pathology
  • Countries : World
Pathology Technology Trends in The United States: VGTI Florida Scientists to Receive US Dollars 3.6  Million in NIH Research Grants

Pathology Technology Trends In The United States: Vgti Florida Scientists To Receive Us Dollars 3.6 Million In Nih Research Grants

  • Industry news
  • 12 hours ago
  • by Business Wire

PORT ST. LUCIE, Fla. --(BUSINESS WIRE)-- Scientists at the Vaccine & Gene Therapy Institute of Florida (VGTI Florida ® ) have been awarded 3 new federal research grants that will further support the Institute?s mission of ?Translating Research Into Health ® .? Dr. Elias Haddad , Ph.D., Associate Member , part of the HIV Vaccine Gro...

  • Industries : Pathology
  • Countries : United States
Pathology Industry: Study shows Salacia may help manage prediabetes

Pathology Industry: Study Shows Salacia May Help Manage Prediabetes

  • Industry news
  • 14 hours ago
  • by Penton Business Media

Clinical research shows standardized extract of Salacia reticulata was safe , may be beneficial in the management of pre-diabetes , mild to moderate hyperlipidemia, as reported by a study published in the Journal of Medicinal Food . The randomized, double-blind, placebo-controlled study evaluated the efficacy , safety of Salacia leaves , root bark extracts in 2...

  • Industries : Pathology
Skin Cancer Sector in The United States and Switzerland: Indianapolis Firm wages war on skin cancer

Skin Cancer Sector In The United States And Switzerland: Indianapolis Firm Wages War On Skin Cancer

  • Industry news
  • 16 hours ago
  • by Associated Press, The

INDIANAPOLIS (AP) ? In a nondescript manufacturing plant on Indianapolis' east side, workers are producing 1 of the most unique weapons in the war on skin cancer. The Industry player that operates the 95,000-square-foot facility with 45 employees at 2855 N. Franklin Road is best known for its Rit line of dyes that brighten , whiten fabric , for its lin...

  • Industries : Pathology
  • Countries : United States
Cardiovascular Disease Industry Overview in The United Kingdom: UNIVERSITY OF LEICESTER -Scientists find potential genetic drivers behind male heart disease risk

Cardiovascular Disease Industry Overview In The United Kingdom: University Of Leicester -scientists Find Potential Genetic Drivers Behind Male Heart Disease Risk

  • Industry news
  • 18 hours ago
  • by M2 Communications

ENP Newswire - 18 June 2013 Release date- 18062013 - University of Leicester scientists have discovered a potential genetic contributor to the increased risk of heart disease among men. A team of researchers including clinicians , scientists have made an important step forward in search of the mechanisms underlying increased risk of coronary artery disease in men who carry a particul...

  • Industries : Pathology
  • Countries : United Kingdom
Pathology Technology Trends: UNIVERSITY OF BRISTOL -Celebrating 100 years of world-class health research

Pathology Technology Trends: University Of Bristol -celebrating 100 Years Of World-class Health Research

  • Industry news
  • 18 hours ago
  • by M2 Communications

ENP Newswire - 18 June 2013 Release date- 17062013 - UNIVERSITY OF BRISTOL -Celebrating 100 years of world-class health research. A pop-up festival of medical science, discussing everything from smoking to how the human memory works, is being held to celebrate 100 years of world-class health research. Academics from the University of Bristol will be sharing their latest work , in...

  • Industries : Pathology
Pathology Technology Trends in The United States: JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes

Pathology Technology Trends In The United States: Jdrf Extends Collaboration With Bd To Develop Combined Infusion And Monitoring Products For People With Type 1 Diabetes

  • Industry news
  • 19 hours ago
  • by PR Newswire

FRANKLIN LAKES, N.J. , NEW YORK , 2013-06-18 /PRNewswire/ -- JDRF , BD ( Becton, Dickinson , Industry player ) (NYSE:BDX) are accelerating the development of new products that combine BD's proprietary insulin infusion , glucose sensing technologies through a new collaboration announced today. This new, 3-year commitment is an extension of existing JDRF-BD collaborations focu...

  • Industries : Pathology
  • Countries : United States
Pathology Innovation Trends in The United States: DARA BioSciences Grants T3D Therapeutics Exclusive Worldwide Rights to Develop and Commercialize DB959

Pathology Innovation Trends In The United States: Dara Biosciences Grants T3d Therapeutics Exclusive Worldwide Rights To Develop And Commercialize Db959

  • Company news
  • 20 hours ago
  • by Marketwire

RALEIGH, NC -- (Marketwired) -- 06/18/13 -- DARA BioSciences, incorporated . (NASDAQ: DARA), a specialty pharmaceutical Industry player focused on oncology supportive care products, announced today that it has granted T3D Therapeutics, incorporated the exclusive worldwide rights to develop , commercialize DB959. DB959 is an oral, highly selective, dual nuclear receptor agonist whose primary target is PPARd ...

  • Industries : Pathology
  • Countries : World
Pathology Technology Trends in The United States: Advanced Treatment Methods, Significant Study Results, Conferences, and Final Study Data Releases - Research Report on Amgen, Celgene, Vertex Pharmaceuticals, MannKind, and Peregrine Pharmaceuticals

Pathology Technology Trends In The United States: Advanced Treatment Methods, Significant Study Results, Conferences, And Final Study Data Releases - Research Report On Amgen, Celgene, Vertex Pharmaceuticals, Mannkind, And Peregrine Pharmaceuticals

  • Industry news
  • 20 hours ago
  • by PR Newswire

NEW YORK , June 18, 2013 /PRNewswire/ -- Today, Wall Street Reports announced new research reports highlighting Amgen incorporated (NASDAQ: AMGN), Celgene Corporation (NASDAQ: CELG), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), MannKind Corp. (NASDAQ: MNKD), , Peregrine Pharmaceuticals incorporated (NASDAQ: PPHM). Today's readers may access these reports free of charge - includin...

  • Industries : Pathology
  • Countries : United States
Infectious Disease Innovation in The United States and Canada: ISA Isotechnika receives NRC funding for NICAM program

Infectious Disease Innovation In The United States And Canada: Isa Isotechnika Receives Nrc Funding For Nicam Program

  • Industry news
  • 20 hours ago
  • by Canjex Publishing Ltd

Isotechnika Pharma incorporated (TSX:ISA) Shares Issued 192,871,249 Last Close 6/17/2013 US Dollars 0.035 Tuesday 2013-06-18 2013 - News Release Dr. Robert Foster reports ISOTECHNIKA PHARMA RECEIVES ADDITIONAL FUNDING FROM THE GOVERNMENT OF CANADA FOR THE PRECLINICAL DEVELOPMENT OF NICAM 440-02 AS AN ANTI-HEPATITIS C AGENT IsotechnincorporatedPharma Inc. has received additional funding from the National Re...

  • Industries : Pathology
  • Countries : United States, Canada
Infectious Disease Technology Trends in The United States and Canada: ISA Isotechnika receives NRC funding for NICAM program

Infectious Disease Technology Trends In The United States And Canada: Isa Isotechnika Receives Nrc Funding For Nicam Program

  • Industry news
  • 20 hours ago
  • by Canjex Publishing Ltd

Isotechnika Pharma incorporated (TSX:ISA) Shares Issued 192,871,249 Last Close 6/17/2013 US Dollars 0.035 Tuesday 2013-06-18 2013 - News Release Dr. Robert Foster reports ISOTECHNIKA PHARMA RECEIVES ADDITIONAL FUNDING FROM THE GOVERNMENT OF CANADA FOR THE PRECLINICAL DEVELOPMENT OF NICAM 440-02 AS AN ANTI-HEPATITIS C AGENT IsotechnincorporatedPharma Inc. has received additional funding from the National Re...

  • Industries : Pathology
  • Countries : United States, Canada
Pathology Innovation in Canada and The United States: Isotechnika Pharma Receives Additional Funding From the Government of Canada for the Preclinical Development of NICAM 440-02 as an Anti-Hepatitis C Agent

Pathology Innovation In Canada And The United States: Isotechnika Pharma Receives Additional Funding From The Government Of Canada For The Preclinical Development Of Nicam 440-02 As An Anti-hepatitis C Agent

  • Industry news
  • 20 hours ago
  • by GlobeNewswire

EDMONTON, Alberta , 2013-06-18 (GLOBE NEWSWIRE) -- Isotechnika Pharma incorporated (TSX:ISA) ("Isotechnika" or the "Industry player") today announced that it has received additional funding from the National Research Council Industrial Research Assistance Program ("NRC-IRAP") for its Non-Immunosuppressive Cyclophilin Antagonist Molecules ("NICAMs") program. NRC-IRAP continues to play an instrument...

  • Industries : Pathology
  • Countries : Canada
Cancer Innovation in The United States: Rexahn Pharmaceuticals incorporated wins patent for novel anti-cancer compounds in the US

Cancer Innovation In The United States: Rexahn Pharmaceuticals Incorporated Wins Patent For Novel Anti-cancer Compounds In The Us

  • Industry news
  • 20 hours ago
  • by M2 Communications

Biopharmaceutical Industry player Rexahn Pharmaceuticals incorporated (NYSE MKT:RNN) reported on Monday the receipt of the patent No. 8,404,698 from the U.S. Patent , Trademark Office, covering the novel quinazoline compounds, their pharmaceutical composition , method for producing an anti-tumor effect. With the grant of today's patent...

  • Industries : Pathology
  • Countries : United States
Cancer Trends in The United States: Rexahn Pharmaceuticals incorporated wins patent for novel anti-cancer compounds in the US

Cancer Trends In The United States: Rexahn Pharmaceuticals Incorporated Wins Patent For Novel Anti-cancer Compounds In The Us

  • Industry news
  • 20 hours ago
  • by M2 Communications

Biopharmaceutical Industry player Rexahn Pharmaceuticals incorporated (NYSE MKT:RNN) reported on Monday the receipt of the patent No. 8,404,698 from the U.S. Patent , Trademark Office, covering the novel quinazoline compounds, their pharmaceutical composition , method for producing an anti-tumor effect. With the grant of today's patent...

  • Industries : Pathology
  • Countries : United States
Cancer Corporate Deals Activity in The United States: Detroit Tigers and Karmanos Cancer Institute team up for 2nd Annual Pink Out the Park Sept. 13

Cancer Corporate Deals Activity In The United States: Detroit Tigers And Karmanos Cancer Institute Team Up For 2nd Annual Pink Out The Park Sept. 13

  • Company news
  • 21 hours ago
  • by PR Newswire

DETROIT , 2013-06-18 /PRNewswire-USNewswire/ -- The Detroit Tigers , the Barbara Ann Karmanos Cancer Institute are teaming up for the 2nd annual Pink Out the Park at the Detroit Tigers vs. Kansas City Royals game Friday, Sept. 13 , at 7:08 p.m. , at Comerica Park . This year's Pink Out the Park event is sponsored by Delta Air Lines . The event raises awareness o...

  • Industries : Pathology
  • Countries : United States
Atrial Fibrillation Trends in The United States: Apama Medical declares Issuance Of Patent For Low Profile Electrodes For Use On Balloons

Atrial Fibrillation Trends In The United States: Apama Medical Declares Issuance Of Patent For Low Profile Electrodes For Use On Balloons

  • Industry news
  • 21 hours ago
  • by PR Newswire

CAMPBELL, Calif. , 2013-06-18 /PRNewswire/ -- Apama Medical, a privately held medical device Industry player focused on the development of next-generation atrial fibrillation technologies, today announced the issuance of U.S. Patent No. 8295902 by the U.S. Patent , Trademark Office (USPTO), titled "Low Profile Electrodes". The patent encompasses low profile electrode assemblies for use on e...

  • Industries : Pathology
  • Countries : United States
Pathology Innovation Trends: MedImmune, AstraZeneca's biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity

Pathology Innovation Trends: Medimmune, Astrazeneca's Biologics Arm, And Ngm Biopharmaceuticals Announce Agreement To Discover And Develop Therapies For Diabetes And Obesity

  • Company news
  • 21 hours ago
  • by M2 Communications

ENP Newswire - 18 June 2013 Release date- 17062013 - AstraZeneca today announced that MedImmune , its global biologics research , development arm, , NGM Biopharmaceuticals, incorporated have entered into an exclusive agreement to discover, develop , commercialise novel therapeutics from NGM's enteroendocrine cell (EEC) programme for the treatment of type 2 diabetes , obesity. EECs r...

  • Industries : Pathology
Pathology Industry Overview in Israel and The United States: RedHill Biopharma declares FDA Acceptance for Review of RHB-103 NDA for Acute Migraine and PDUFA Goal Date of 2014-02-03

Pathology Industry Overview In Israel And The United States: Redhill Biopharma Declares Fda Acceptance For Review Of Rhb-103 Nda For Acute Migraine And Pdufa Goal Date Of 2014-02-03

  • Industry news
  • 22 hours ago
  • by GlobeNewswire

The RHB-103 New Drug Application (NDA) for marketing approval in the U.S. is subject to a standard ten-month review period , will have a Prescription Drug User Fee Act (PDUFA) action date (targeted date for completion of FDA review) of 2014-02-03 The Industry player recently received from FDA a PDUFA fee waiver , a subsequent refund of US Dollars 979400 RHB-103 is a propr...

  • Industries : Pathology
  • Countries : Israel, United States
Pathology Market Overview in Europe: Lax marketing regulations contribute to obesity crisis in children

Pathology Market Overview In Europe: Lax Marketing Regulations Contribute To Obesity Crisis In Children

  • Industry news
  • 22 hours ago
  • by M2 Communications

Copenhagen - WHO calls for tighter controls on the marketing to children of foods high in saturated , trans fats, free sugars , salt, in order to fight childhood obesity. Tightening restrictions on marketing is central to this fight, as reported by a new report from the WHO Regional Office for Europe : Marketing of foods high in fat, salt , sugar to children.[1] Unfortunately, marketi...

  • Industries : Pathology
  • Countries : Europe
Musculoskeletal Disorder Innovation Trends in Europe: Amgen and AstraZeneca highlight data to be presented at European League Against Rheumatism annual meeting.

Musculoskeletal Disorder Innovation Trends In Europe: Amgen And Astrazeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting.

  • Company news
  • 1 day ago
  • by Elsevier CBNB

Amgen , AstraZeneca , with its biologics research , development arm MedImmune , announced that they will present data from a Phase ...

  • Industries : Pathology
  • Countries : Europe
Pathology Innovation Trends in South Korea and The United States: Healthy foods? Reversatol in rice.

Pathology Innovation Trends In South Korea And The United States: Healthy Foods? Reversatol In Rice.

  • Company news
  • 1 day ago
  • by Elsevier CBNB

Researchers from Chonbuk National University in South Korea have developed a strain of rice (DJ526) enriched with reversatol, a chemical known to fight obesity, diabetes, cancers, , other diseases. The supplement, reported to be a US Dollars 40 M business in the US, is repo...

  • Industries : Pathology
  • Countries : South Korea, United States
Pathology Corporate Deals Activity in The United States: American Medical Experts to Make Doctor's Rounds in Dalian

Pathology Corporate Deals Activity In The United States: American Medical Experts To Make Doctor's Rounds In Dalian

  • Company news
  • 1 day ago
  • by Information Solutions

Beijing , 2013-06-17 -- Dalian Medical University (DLMEDU) signed an agreement for academic cooperation , exchanges with the University of Texas Health Science Centre (UTHealth) on June 10 at No.1 Hospital Affiliated to DLMEDU. This is another in-depth cooperation with a world's renowned university after DLMEDU set up a partnership with the University of Virginia , the United States o...

  • Industries : Pathology
  • Countries : United States
Pathology Competitive Position in New Zealand: New Zealand academic

Pathology Competitive Position In New Zealand: New Zealand Academic

  • Company news
  • 1 day ago
  • by Xinhua News Agency

WELLINGTON , 2013-06-18 (Xinhua) -- Airlines around the world are discriminating against pregnant women with unjust "fit to fly" rules, as reported by a New Zealand academic. Many carriers imposed a total ban on pregnant women flying past a deadline that could vary from 28 to 37 weeks of pregnancy, University of Canterbury Associate Professor Annick Masselot wrote in a European C...

  • Industries : Pathology
  • Countries : New Zealand
Pathology Innovation Trends in India: Intellectual Property India Publishes Patent Application for 'Spongy Dessert- A Herbal Biotech Rassogolla' Filed by Pankaj Garg

Pathology Innovation Trends In India: Intellectual Property India Publishes Patent Application For 'spongy Dessert- A Herbal Biotech Rassogolla' Filed By Pankaj Garg

  • Company news
  • 1 day ago
  • by HT Media

MUMBAI, India , June 18 -- Intellectual Property India has published a patent application (1445/DEL/2013 A) filed by Pankaj Garg , Jaipur , Rajasthan on 2013-05-15 for a 'spongy dessert-a herbal biotech rassogolla.' The application for the patent - which was invented by Pankaj Garg , Pramod Kumar Raghav , Nakuleshwar Dut Jasuja, Rakesh Kumar Sharma , Richa Sharma - was published ...

  • Industries : Pathology
  • Countries : India
Pathology Innovation Trends in The United States: Millennium chief faces questions, uncertainties

Pathology Innovation Trends In The United States: Millennium Chief Faces Questions, Uncertainties

  • Company news
  • 1 day ago
  • by Boston Globe, The

CAMBRIDGE ? When you take over 1 of the Boston region?s largest biopharmaceutical companies after the longtime chief executive has quit abruptly ? , as its parent Industry player is shrinking research , development globally ? you will be peppered with inquiries. ?There?s a lot of questions about what?s happening at Millennium,?? Anna Protopapas , the new president of Millennium Pharmaceuti...

  • Industries : Pathology
  • Countries : United States
Cancer Innovation Trends in The United Kingdom: Cancer experts in new drug research.

Cancer Innovation Trends In The United Kingdom: Cancer Experts In New Drug Research.

  • Company news
  • 1 day ago
  • by Gale Group

DRUGS giant AstraZeneca has invited 2 leading research bodies to test a potentially lifesaving drug at its Alderley Park site. Experts from Cancer Research UK , Manchester University are to use specialist screening facilities at the site near ...

  • Industries : Pathology
  • Countries : United Kingdom
Pathology Innovation Trends in The United States: U.S. Patent granted to The Ohio State University Research Foundation on 2013-06-18 for

Pathology Innovation Trends In The United States: U.s. Patent Granted To The Ohio State University Research Foundation On 2013-06-18 For "methods And Compositions For Inducing Deregulation Of Epha7 And Erk...

  • Company news
  • 1 day ago
  • by HT Media

U.S. Patent granted to The Ohio State University Research Foundation on 2013-06-18 for "Methods , compositions for inducing deregulation of EPHA7 , ERK phosphorylation in human acute leukemias" (Ohio Inventor) ALEXANDRIA, Va. , June 18 -- United States Patent no. 8,466,119, issued on June 18 , was assigned to The Ohio State University Research Foundation ( Columbus, Ohio ). "Method...

  • Industries : Pathology
  • Countries : United States
Anxiety Disorder Innovation Trends in The United States: U.S. Patent granted to Advanced Neuromodulation Systems on 2013-06-18 for

Anxiety Disorder Innovation Trends In The United States: U.s. Patent Granted To Advanced Neuromodulation Systems On 2013-06-18 For "method Of Treating Depression, Mood Disorders And Anxiety Disorders Using...

  • Company news
  • 1 day ago
  • by HT Media

U.S. Patent granted to Advanced Neuromodulation Systems on 2013-06-18 for "Method of treating depression, mood disorders , anxiety disorders using neuromodulation" (Canadian Inventors) ALEXANDRIA, Va. , June 18 -- United States Patent no. 8,467,878, issued on June 18 , was assigned to Advanced Neuromodulation Systems incorporated ( Plano, Texas ). "Method of treating depression, mood disorde...

  • Industries : Pathology
  • Countries : United States
Cancer Innovation Trends in The United States: U.S. Patent granted to The Ohio State University Research Foundation on 2013-06-18 for

Cancer Innovation Trends In The United States: U.s. Patent Granted To The Ohio State University Research Foundation On 2013-06-18 For "ultraconserved Regions Encoding Ncrnas" (ohio Inventor)

  • Company news
  • 1 day ago
  • by HT Media

ALEXANDRIA, Va. , 2013-06-18 -- United States Patent no. 8,465,918, issued on June 18 , was assigned to The Ohio State University Research Foundation ( Columbus, Ohio ). "Ultraconserved areas encoding ncRNAs" was invented by Carlo M. Croce ( Columbus, Ohio ). as reported by the abstract* released by the U.S. Patent & Trademark Office...

  • Industries : Pathology
  • Countries : United States
Alzheimer's Disease Innovation Trends in The United States: U.S. Patent granted to Trustees of Dartmouth College on 2013-06-18 for

Alzheimer's Disease Innovation Trends In The United States: U.s. Patent Granted To Trustees Of Dartmouth College On 2013-06-18 For "method Of Selectively Inhibiting The Activity Of Acat1 In The Treatment Of...

  • Company news
  • 1 day ago
  • by HT Media

U.S. Patent granted to Trustees of Dartmouth College on 2013-06-18 for "Method of selectively inhibiting the activity of ACAT1 in the treatment of Alzheimer's disease" (New Hampshire Inventors) ALEXANDRIA, Va. , June 18 -- United States Patent no. 8,466,121, issued on June 18 , was assigned to Trustees of Dartmouth College ( Hanover, N.H. ). "Method of selectively inhibiting the activi...

  • Industries : Pathology
  • Countries : United States

Reportlinker.com © Copyright 2013. All rights reserved.

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.